These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34322403)

  • 1. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
    Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
    J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
    Eze P; Mezue KN; Nduka CU; Obianyo I; Egbuche O
    Am J Cardiovasc Dis; 2021; 11(1):93-107. PubMed ID: 33815925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis.
    Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P
    J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
    Das RR; Behera B; Mishra B; Naik SS
    Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment.
    Ghazy RM; Almaghraby A; Shaaban R; Kamal A; Beshir H; Moursi A; Ramadan A; Taha SHN
    Sci Rep; 2020 Dec; 10(1):22139. PubMed ID: 33335141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine.
    Sarayani A; Cicali B; Henriksen CH; Brown JD
    Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
    Shah S; Das S; Jain A; Misra DP; Negi VS
    Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Chloroquine and Hydroxychloroquine Safety Profiles: A Systematic Review and Meta-Analysis.
    Ren L; Xu W; Overton JL; Yu S; Chiamvimonvat N; Thai PN
    Front Pharmacol; 2020; 11():562777. PubMed ID: 33154723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions.
    Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V
    Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
    Kumar J; Jain S; Meena J; Yadav A
    J Infect Chemother; 2021 Jun; 27(6):882-889. PubMed ID: 33678548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
    Chivese T; Musa OAH; Hindy G; Al-Wattary N; Badran S; Soliman N; Aboughalia ATM; Matizanadzo JT; Emara MM; Thalib L; Doi SAR
    Travel Med Infect Dis; 2021; 43():102135. PubMed ID: 34265436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
    Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
    Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy.
    Celotto S; Veronese N; Barbagallo M; Ometto F; Smith L; Pardhan S; Barnett Y; Ilie PC; Soysal P; Lagolio E; Kurotschka PK; Tonelli R; Demurtas J
    Int J Infect Dis; 2021 Feb; 103():599-606. PubMed ID: 33316389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials.
    Ebina-Shibuya R; Namkoong H; Horita N; Kato H; Hara Y; Kobayashi N; Kaneko T
    J Thorac Dis; 2021 Jan; 13(1):202-212. PubMed ID: 33569200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes associated with chloroquine, hydroxychloroquine, and azithromycin: a retrospective analysis of individual case safety reports from VigiBase.
    Saint-Gerons DM; Tabarés-Seisdedos R
    Eur J Clin Pharmacol; 2021 Oct; 77(10):1513-1521. PubMed ID: 33938974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Rouamba T; Ouédraogo E; Barry H; Yaméogo NV; Sondo A; Boly R; Zoungrana J; Ouédraogo AR; Tahita MC; Poda A; Diendéré AE; Ouedraogo AS; Valea I; Traoré I; Tarnagda Z; Drabo MK; Tinto H;
    Int J Infect Dis; 2022 May; 118():224-229. PubMed ID: 35227869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of chloroquine and hydroxychloroquine for COVID-19: A comprehensive evidence synthesis of clinical, animal, and in vitro studies.
    Barzkar F; Ranjbar M; Sioofy-Khojine AB; Khajehazad M; Vesal Azad R; Moradi Y; Baradaran HR
    Med J Islam Repub Iran; 2020; 34():171. PubMed ID: 33816370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.